Stay up-to-date with the latest news and information from the drug testing industry by subscribing to Results, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2024 Quest Diagnostics Incorporated. All rights reserved.
National Treatment Admissions for Opiates Continue to Increase
Admissions for the primary abuse of opiates such as oxycodone, hydrocodone, and codeine, have increased steadily from 1.0 percent in 1997 to 8.6 percent in 2010, according to the national Treatment Episode Data Set (TEDS). Opiates now surpass cocaine (8.1 percent) and Methamphetamine (5.7 percent) as the primary substance of abuse. This trend reflects a growing use and misuse of prescription opiates in today’s headlines.
Click here to view a PDF of the complete CESAR report.
For more information about drug testing, visit our website.